Growth Metrics

Novartis Ag (NVS) Change in Taxes (2020 - 2026)

Novartis Ag's Change in Taxes history spans 7 years, with the latest figure at -$683.0 million for Q1 2026.

  • On a quarterly basis, Change in Taxes rose 14.41% to -$683.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$2.3 billion, a 10.3% decrease, with the full-year FY2025 number at -$814.0 million, changed N/A from a year prior.
  • Change in Taxes hit -$683.0 million in Q1 2026 for Novartis Ag, up from -$814.0 million in the prior quarter.
  • Over the last five years, Change in Taxes for NVS hit a ceiling of $441.0 million in Q1 2024 and a floor of -$814.0 million in Q4 2025.
  • Historically, Change in Taxes has averaged -$364.5 million across 5 years, with a median of -$403.0 million in 2023.
  • The widest YoY moves for Change in Taxes: up 219.19% in 2024, down 412.82% in 2024.
  • Tracing NVS's Change in Taxes over 5 years: stood at -$254.0 million in 2022, then soared by 202.76% to $261.0 million in 2023, then plummeted by 278.16% to -$465.0 million in 2024, then crashed by 75.05% to -$814.0 million in 2025, then rose by 16.09% to -$683.0 million in 2026.
  • Business Quant data shows Change in Taxes for NVS at -$683.0 million in Q1 2026, -$814.0 million in Q4 2025, and -$266.0 million in Q3 2025.